Related Experiment Videos
[Advance in cancer chemotherapy]
1Cancer Institute, Japanese Foundation for Cancer Research.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|July 20, 1999
Summary
Cancer treatment has evolved with combination drug therapies and supportive care improving patient outcomes. Future research focuses on novel molecular targets for enhanced anticancer drug development.
Area of Science:
- Oncology
- Pharmacology
Context:
- Over 40 anticancer drugs are currently in use, with a history of development since the mid-20th century.
- Pre-clinical and clinical studies indicate that combination chemotherapy can be more effective than monotherapy for certain human malignancies.
- Recent advancements include biochemical modulation for digestive organ cancers and supportive therapies to manage adverse drug reactions, improving patient quality of life (QOL).
Purpose:
- To review the evolution of anticancer drug development and treatment strategies.
- To highlight the efficacy of combination therapies and supportive care in cancer treatment.
- To discuss emerging trends in cancer therapy, including novel molecular targets.
Summary:
- Anticancer drug development has progressed significantly, with combination therapies and supportive care strategies enhancing treatment efficacy and patient QOL.
- Biochemical modulation is a recent approach for digestive organ cancers, while supportive therapies mitigate side effects.
- The field is advancing towards novel molecularly targeted drugs for 21st-century cancer treatment.
Impact:
- Improved cure rates for specific human malignancies through combination drug regimens.
- Enhanced quality of life for cancer patients due to effective supportive therapies.
- Paving the way for next-generation cancer treatments targeting novel molecular pathways.